About Us

Scientists at Planet Biotechnology identify and develop promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. We routinely adapt our antibody and receptor-antibody products for rapid production in non-food, non-feed green plants grown in greenhouses. This same approach has been used by others to produce three anti-Ebola virus antibodies that are undergoing clinical trials in Africa.

 

 

 

 

 

 

 

 
 
 
 
arrow2 News
 
arrow2 Management Team
 
arrow2 Publications
arrow2 Current Job Openings